CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

Jin Hyoung Kang, Jung Hye Kwon, Yun-Gyoo Lee, Keon Uk Park, Ho Jung An, Joohyuk Sohn, Young Mi Seol, Hyunwoo Lee, Hwan-Jung Yun, Jin Seok Ahn, Ji Hyun Yang, Hunho Song, Dong-Hoe Koo, Jin Young Kim, Gun Min Kim, Hwa Jung Kim

Cancer Research and Treatment. 2020;52(3):907-916. Published online 2020 March 18 DOI: https://doi.org/10.4143/crt.2019.713

1287 POSTER Palonosetron plus aprepitant and dexamethasone is a highly effective combination to prevent chemotherapy-induced nausea & vomiting after emetogenic chemotherapy

European Journal of Cancer Supplements. 2005;3(2):371-372

Link1 Link2

Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting

J.H. Kwon, J.-H. Kang, Y.-G. Lee, K.U. Park, H.J. An, J. Sohn, Y.M. Seol, H. Lee, H.-J. Yun, J.S. Ahn, H.J. Kim

Annals of Oncology. 2018;29:viii610

Link1 Link2 Link3

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

Cancer Research and Treatment. 2020;52(3):907-916

Link1

Link2 Link3

The Efficacy of Triplet Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients Receiving Highly Emetogenic Chemotherapy: Palonosetron (PALO), Aprepitant (APR), and Dexamethasone (DEX)

H. Yoshizawa, K. Sato, M. Makino, O. Kobayashi, H. Tanaka, S. Miura, S. Watanabe, J. Tanaka, H. Kagamu, N. Ichiei

Annals of Oncology. 2012;23:ix509

Link1 Link2

PCN22 COST-EFFECTIVENESS OF PALONOSETRON FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY

K Rely, KA Pierre, EG Salinas

Value in Health. 2009;12(7):A496

Link1 Link2

Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy

Toshimichi Miya, , Kunihiko Kobayashi, Mitsunori Hino, Masahiro Ando, Susumu Takeuchi, Masahiro Seike, Kaoru Kubota, Akihiko Gemma

SpringerPlus. 2016;5(1):

Link1

Link2 Link3

342P Comparison of 0.25 mg versus 0.75 mg of palonosetron in combination with aprepitant and dexamethasone for prevention of chemotherapy-induced nausea and vomiting following cisplatin-containing chemotherapy in patients with esophageal cancer

S. Horasawa, Y. Nakamura, S. Shimada, H. Taniguchi, T. Kojima, T. Aoyama, T. Yoshino

Annals of Oncology. 2020;31:S1374

Link1 Link2

3072 Palonosetron plus a three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

G. Mansueto, F. Longo, R. De Sanctis, V. Lapadula, S. Quadrini, I. D'Antoni, R. Grande, E. Cortesi, T. Gamucci, M. DiSeri

European Journal of Cancer Supplements. 2009;7(2):196

Link1 Link2

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

L. Zhang, S. Lu, J. Feng, A. Dechaphunkul, J. Chang, D. Wang, S. Chessari, C. Lanzarotti, K. Jordan, M. Aapro

Annals of Oncology. 2018;29(2):452-458

Link1 Link2 Link3

Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy

Takeshi Ioroi, Junya Furukawa, Manabu Kume, Sachi Hirata, Yuko Utsubo, Naomi Mizuta, Hideaki Miyake, Masato Fujisawa, Midori Hirai

Supportive Care in Cancer. 2017;

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.